Weaver C. Barksdale Associates buys $2.1 Million stake in MEDNAX Inc (MD)

MEDNAX Inc (MD) : Weaver C. Barksdale Associates scooped up 24 additional shares in MEDNAX Inc during the most recent quarter end , according to a recent disclosure to the SEC on Apr 5, 2016. The investment management firm now holds a total of 32,198 shares of MEDNAX Inc which is valued at $2.1 Million.MEDNAX Inc makes up approximately 1.56% of Weaver C. Barksdale Associates’s portfolio.

On the company’s financial health, MEDNAX Inc reported $1.13 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Feb 4, 2016. Analyst had a consensus of $1.12. The company had revenue of $741.70 million for the quarter, compared to analysts expectations of $747.86 million. The company’s revenue was up 14.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.89 EPS.

Many Wall Street Analysts have commented on MEDNAX Inc. Shares were Reiterated by Stifel on Mar 8, 2016 to “Buy” and Lowered the Price Target to $ 76 from a previous price target of $81 .MEDNAX Inc was Downgraded by Susquehanna to ” Neutral” on Mar 7, 2016.

MEDNAX Inc opened for trading at $63.85 and hit $64.59 on the upside on Monday, eventually ending the session at $64.21, with a gain of 0.69% or 0.44 points. The heightened volatility saw the trading volume jump to 8,17,548 shares. Company has a market cap of $6,023 M.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Leave a Reply

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.